RNS Number:1294O
GW Pharmaceuticals PLC
18 December 2006



                              GW Pharmaceuticals PLC

                                       ("GW")

In conformity with the Transparency Directive's transitional provision 6, GW
hereby provides notification of the  following information:

GW's issued capital consists of 120,076,035 ordinary shares with voting rights.
Therefore, the total number of voting  rights in GW is 120,076,035.

The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if  they are required to notify their
interest in, or a change to their interest in, GW under the FSA's Disclosure and
Transparency Rules.

For further information, please contact:

GW Pharmaceuticals PLC                                      +44 (0)20 7831 3113
Dr Geoffrey Guy, Chairman
Justin Gover, Managing Director





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
TVRGGMMZDRZGVZM
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.